|
Julia C. Gage
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute. Early life and educationGage completed a B.A. in political science with a concentration in Latin American studies from Grinnell College in 1995.[1] From October 1996 to August 1998, she worked for AFL–CIO as an Organizing Institute apprentice and later a union organizer for the Service Employees International Union.[1] Gage worked for the Maxwell Stamp, Inc. in Washington, D.C. as a business development and research assistant from September 1998 to March 2000.[1] From March 2000 to February 2002, Gage was a research assistant and consultant in the non-communicable disease program of the Pan American Health Organization where she primarily used Spanish and designed study protocols.[1] In 2001, she earned a M.P.H. in international health promotion from the George Washington Milken Institute School of Public Health.[1] Between September 2002 to August 2004, Gage worked at the Health Resources and Services Administration, first as a scholar and then as a public health analyst in the office of data and information management in the Maternal and Child Health Bureau.[1] In 2005, Gage joined the National Cancer Institute's (NCI) division of cancer epidemiology and genetics (DCEG) as a pre-doctoral fellow while pursuing a Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health.[2] She completed her Ph.D. in epidemiology in 2008. Her dissertation was titled, An evaluation of visual triage of human papillomavirus-positive women.[1] Janet Holbrook was her doctoral advisor and Mark Schiffman of NCI was her mentor.[1] Gage completed a postdoctoral fellowship at the NCI, first in the hormonal and reproductive epidemiology branch, and then in the clinical genetics branch (CGB).[2] CareerGage has worked as a staff scientist in the CGB since 2014. She works on projects with Nicolas Wentzensen, Philip E. Castle, and Schiffman.[2] Gage is focused on translating discoveries regarding the natural history of human papillomavirus (HPV) into improved screening and diagnosis for cervical precancer.[2] In particular, she investigates improved targeting of underlying precancer through HPV tests and biomarkers.[2] Gage also pursues scientific investigations to identify and bring new technologies for cervical cancer prevention to low medical resource settings.[2] Along with Wentzensen, Gage serves as co-investigator for multiple studies within the DCEG collaboration with Kaiser Permanente of Northern California (KPNC).[2] She is a co-investigator of the Improving Risk Informed HPV Screening (IRIS) Study, involving HPV and cytology specimens from over 77,000 participants.[2] Under the leadership of Schiffman, Gage is part of a team of investigators at the NCI and the National Library of Medicine developing a simple, low-cost visual cervical screening method called automated visual evaluation (AVE).[2] She leads the development of a deep learning algorithm that will inform clinical management decisions when testing positive.[2] Gage serves as lead NCI investigator under the direction of Schiffman to evaluate the effectiveness and cost-effectiveness of cervical screening and triage strategies in the Management of Risk of Cervical Cancer (MARCO) project.[2] Under the supervision of Castle, division of cancer prevention, Gage is the lead NCI scientist for an NCI grant-funded cross-sectional study of HPV screening and triage strategies among 5,000 women living with HIV. She is also the lead NCI scientist on a second Rwandan study of the impact of prophylactic HPV vaccination on HPV immunity and HPV infection in women living with HIV.[2] Gage received the Hubert H. Humphrey Award for Service to America in 2022.[2] See also
References
 This article incorporates public domain material from websites or documents of the National Institutes of Health.
Information related to Julia C. Gage |
||||||||||||||||||||
